Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
11m agoSunrun Prices $584 million Securitization of Residential Solar and Storage Assets
11m agoMadison Air Schedules First Quarter 2026 Earnings Conference Call and Webcast
35m agoUltra Clean Announces Retirement of the Chief Financial Officer Sheri Savage
35m agoGridAI Technologies Corp. Announces Receipt of NASDAQ Notice Regarding Late Form 10-K Filing
36m agoRush Enterprises, Inc. Reports First Quarter 2026 Results, Announces $0.19 Per Share Dividend

Oryzon Genomics Sa

About

Oryzon Genomics Sa (MC:ORY) — investor relations, events, news, and company updates on 6ix.

Latest News

Feb 27 2026
ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31st, 2025
Feb 19 2026
ORYZON to Participate in Upcoming Events in February and March
Feb 12 2026
ORYZON Announces Appointment of Rolando Gutierrez-Esteinou, M.D., as Chief Medical Officer for CNS
Feb 9 2026
ORYZON Announces First Patient Dosed in an Investigator-Initiated Phase Ib Study of Iadademstat in Extensive Stage Small Cell Lung Cancer
Feb 2 2026
ORYZON Strengthens Patent Portfolio for Vafidemstat With New Decision to Grant in Japan

Financials

Revenue
€10.93 M
Market Cap
€220 M
EPS
-0.03

Community Chat

Ask AI

6ix6ixAIEvents